Market Tracker

09/21 5:16pm ET

Nektar Therapeutics (NASDAQ:NKTR)

21.87
Delayed Data
As of 4:00pm ET
 +0.48 / +2.24%
Today’s Change
11.41
Today|||52-Week Range
24.88
+78.24%
Year-to-Date

Today’s Trading

Previous close21.39
Today’s open21.37
Day’s range21.11 - 21.98
Volume750,616
Average volume (3 months)1,181,020
Market cap$3.3B
Dividend yield--
Data as of 4:00pm ET, 09/21/2017

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)+15.91%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book37.19

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...-0.89-1.01%
AVXSAveXis Inc-1.20-1.23%
XONIntrexon Corp-0.14-0.74%
BPMCBlueprint Medicines ...+0.60+0.97%
Data as of 4:02pm ET, 09/21/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)$0.11
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts